You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vinorelbine

Showing 1 - 25 of 172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inetetamab Combined With Pyrotinib and Vinorelbine as First-line

Recruiting
  • Breast Neoplasms
  • Nanjing, Jiangsu, China
    Jiangsu Provincial People's Hospital
Mar 16, 2023

Anaplastic Large Cell Lymphoma, Vinorelbine Trial in Shanghai (Vinorelbine)

Completed
  • Anaplastic Large Cell Lymphoma
  • Vinorelbine
  • Vinorelbine
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
Jul 23, 2022

Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Malignant Pleural Mesothelioma (MPM)
  • Vinorelbine
  • Marseille, France
    Assistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022

Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)

Recruiting
  • Rhabdomyosarcoma
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
May 13, 2022

NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma Breast
  • Vinorelbine
  • +4 more
  • Suzhou, China
    Second Affiliated Hospital of Soochow University
Oct 29, 2022

Breast Carcinoma, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Chicago

Not yet recruiting
  • Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Nov 14, 2023

HER2-positive Advanced Breast Cancer Trial in Tianjin (Pyrotinib Maleate, Vinorelbine)

Completed
  • HER2-positive Advanced Breast Cancer
  • Pyrotinib Maleate
  • Vinorelbine
  • Tianjin, China
    Tianjin Cancer Hospital
Apr 6, 2022

Mesothelioma Trial in Cardiff (Vinorelbine, Active Symptom Control)

Completed
  • Mesothelioma
  • Vinorelbine
  • Active Symptom Control
  • Cardiff, United Kingdom
    Wales Cancer Trials Unit
Oct 4, 2021

Non Hodgkin Lymphoma Trial (Liposomal Mitoxantrone Hydrochloride dose level 1, Liposomal Mitoxantrone Hydrochloride dose level

Not yet recruiting
  • Non Hodgkin Lymphoma
  • Liposomal Mitoxantrone Hydrochloride dose level 1
  • +6 more
  • (no location specified)
Mar 17, 2022

HER2-positive Metastatic Breast Cancer, Locally Advanced HER2 Positive Breast Carcinoma Trial in Spain (Tucatinib, Trastuzumab,

Not yet recruiting
  • HER2-positive Metastatic Breast Cancer
  • Locally Advanced HER2 Positive Breast Carcinoma
  • Cádiz, Andalucía, Spain
  • +17 more
Jan 16, 2023

Anaplastic Large Cell Lymphoma, Vinorelbine Trial in Shanghai (Vinorelbine)

Recruiting
  • Anaplastic Large Cell Lymphoma
  • Vinorelbine
  • Vinorelbine
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center
Jul 28, 2021

Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)

Recruiting
  • Neoplasms
  • +2 more
  • Leiden, Netherlands
    Leids Universitair Medisch Centrum
Aug 14, 2023

Metastatic Breast Cancer Trial (SKB264, Eribulin, Capecitabine)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Oct 7, 2023

NSCLC Trial in France (Atezolizumab, Vinorelbine)

Completed
  • Non-small Cell Lung Cancer
  • Aix-en-Provence, France
  • +12 more
May 11, 2022

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

HER2-negative Breast Cancer, Advanced Breast Cancer Trial in Guangzhou (Organoid-guided treatment, Taxane, Capecitabine)

Not yet recruiting
  • HER2-negative Breast Cancer
  • Advanced Breast Cancer
  • Organoid-guided treatment
  • +5 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Oct 22, 2023

Metastatic Breast Cancer Trial (Pyrotinib, Vinorelbine, Inetetamab)

Not yet recruiting
  • Metastatic Breast Cancer
  • (no location specified)
Jul 11, 2021

Advanced Cancer, Metastatic Cervical Cancer Trial in Albuquerque, Yerevan (Balstilimab (BAL), Topotecan, Vinorelbine)

Withdrawn
  • Advanced Cancer
  • Metastatic Cervical Cancer
  • Balstilimab (BAL)
  • +5 more
  • Albuquerque, New Mexico
  • +2 more
Oct 3, 2022

Metastatic Breast Cancer Trial in Shanghai (Vinorelbine, DDP)

Recruiting
  • Metastatic Breast Cancer
  • Shanghai, China
    Fudan University Cancer Hospital
Apr 19, 2022

Metastatic Breast Cancer Trial in Napoli (vinorelbine, carboplatin, trastuzumab)

Active, not recruiting
  • Metastatic Breast Cancer
  • vinorelbine
  • +2 more
  • Napoli, Italy
    Istituto Nazionale dei Tumori, Divisione di Oncologia Medica C
Mar 3, 2021

Standard Anti-microtubule Drugs as Assessed by Early Tumor

Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 10, 2021

Breast Cancer Trial in Italy (Paclitaxel, Cyclophosphamide, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Aviano, Italy
  • +19 more
Aug 31, 2022

Triple Negative Breast Cancer Trial in Shanghai (Personalized treatment guided by mini-PDX and RNA sequencing, Nab paclitaxel,

Recruiting
  • Triple Negative Breast Cancer
  • Personalized treatment guided by mini-PDX and RNA sequencing
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Metastatic Triple Negative Breast Cancer Trial (pembrolizumab, capecitabine, eribulin)

Completed
Has Results
  • Metastatic Triple Negative Breast Cancer
  • pembrolizumab
  • +4 more
  • (no location specified)
Nov 9, 2021

Breast Cancer Metastatic Trial in Worldwide (MCLA-128, Trastuzumab, Vinorelbine)

Active, not recruiting
  • Breast Cancer Metastatic
  • Los Angeles, California
  • +24 more
Aug 10, 2022